SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
Received date: 24 Oct 2017
Accepted date: 09 Jan 2018
Published date: 18 Oct 2018
Copyright
Wnt signaling has emerged as a major regulator of tissue development by governing the self-renewal and maintenance of stem cells in most tissue types. As a key upstream regulator of the Wnt pathway, the transmembrane E3 ligase ZNRF3 has recently been established to play a role in negative regulation of Wnt signaling by targeting Frizzled (FZD) receptor for ubiquitination and degradation. However, the upstream regulation of ZNRF3, in particular the turnover of ZNRF3, is still unclear. Here we report that ZNRF3 is accumulated in the presence of proteasome inhibitor treatment independent of its E3-ubiquitin ligase activity. Furthermore, the Cullin 1-specific SCF complex containing β-TRCP has been identified to directly interact with and ubiquitinate ZNRF3 thereby regulating its protein stability. Similar with the degradation of β-catenin by β-TRCP, ZNRF3 is ubiquitinated by β-TRCP in both CKI-phosphorylation-and degron-dependent manners. Thus, our findings not only identify a novel substrate for β-TRCP oncogenic regulation, but also highlight the dual regulation of Wnt signaling by β-TRCP in a contextdependent manner where β-TRCP negatively regulates Wnt signaling by targeting β-catenin, and positively regulates Wnt signaling by targeting ZNRF3.
Key words: ZNRF3; β-TRCP; Wnt; ubiquitination; CKI
Yanpeng Ci , Xiaoning Li , Maorong Chen , Jiateng Zhong , Brian J. North , Hiroyuki Inuzuka , Xi He , Yu Li , Jianping Guo , Xiangpeng Dai . SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation[J]. Protein & Cell, 2018 , 9(10) : 879 -889 . DOI: 10.1007/s13238-018-0510-2
1 |
Akhoondi S
|
2 |
Behrens J
|
3 |
Busino L
|
4 |
Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480
|
5 |
de Bie P, Ciechanover A (2011) Ubiquitination of E3 ligases: selfregulation of the ubiquitin system via proteolytic and nonproteolytic mechanisms. Cell Death Differ 18:1393–1402
|
6 |
Espada J, Calvo MB, Diaz-Prado S, Medina V (2009) Wnt signalling and cancer stem cells. Clin Transl Oncol 11:411–427
|
7 |
Fuchs SY, Spiegelman VS, Kumar KG (2004) The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene 23:2028–2036
|
8 |
Gao D
|
9 |
Goldstein B, Takeshita H, Mizumoto K, Sawa H (2006) Wnt signals can function as positional cues in establishing cell polarity. Dev Cell 10:391–396
|
10 |
Guardavaccaro D
|
11 |
Guo J
|
12 |
Hao HX
|
13 |
Hart M
|
14 |
Kimelman D, Xu W (2006) beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25:7482–7491
|
15 |
Koo BK
|
16 |
Kudo Y
|
17 |
Lammi L
|
18 |
Lustig B
|
19 |
MacDonald BT, He X (2012) Frizzled and LRP5/6 receptors for Wnt/beta-catenin signaling. Cold Spring Harb Perspect Biol 4:12
|
20 |
Morin PJ
|
21 |
Nakayama K
|
22 |
Nusse R, Clevers H (2017) Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985–999
|
23 |
Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99–109
|
24 |
Peifer M, Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science 287:1606–1609
|
25 |
Rubinfeld B
|
26 |
Rubinfeld B
|
27 |
Saitoh T, Katoh M (2001) Expression profiles of betaTRCP1 and betaTRCP2, and mutation analysis of betaTRCP2 in gastric cancer. Int J Oncol 18:959–964
|
28 |
Sarikas A, Hartmann T, Pan ZQ (2011) The cullin protein family. Genome Biol 12:220
|
29 |
Scaglione KM
|
30 |
Shen M, Schmitt S, Buac D, Dou QP (2013) Targeting the ubiquitinproteasome system for cancer therapy. Expert Opin Ther Targets 17:1091–1108
|
31 |
Shimizu K
|
32 |
Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW (1997) F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91:209–219
|
33 |
Soucy TA
|
34 |
Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130–1134
|
35 |
Spencer E, Jiang J, Chen ZJ (1999) Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev 13:284–294
|
36 |
Spranger S, Bao R, Gajewski TF (2015) Melanoma-intrinsic betacatenin signalling prevents anti-tumour immunity. Nature 523:231–235
|
37 |
Toomes C
|
38 |
Van Wesenbeeck L
|
39 |
Wang Z, Liu P, Inuzuka H, Wei W (2014) Roles of F-box proteins in cancer. Nat Rev Cancer 14:233–247
|
40 |
Wang Z
|
41 |
Welcker M, Clurman BE (2008) FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8:83–93
|
42 |
Westbrook TF
|
43 |
Yang K
|
/
〈 |
|
〉 |